Search
for

    Sort by

    Research 451–480 of 1000+

    1. 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond European Urology Supplements · 2006 · 2 citations
    2. 복분자 미숙과 추출물이 전립선암 세포주와 전립선비대 백서모델에 미치는 영향 Journal of the Korean Society of Food Science and Nutrition · 2014 · 1 citations
    3. Chemoprävention des Prostatakarzinoms - Ein Plädoyer Aktuelle Urologie · 2012 · 1 citations
    4. Triple Hormonal Blockade (ADT3): A Patient’s Perspective Oncogen · 2019
    5. 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia Actas urológicas españolas · 2018
    6. Editorial Comment Urology · 2013
    7. Reply Urology · 2009
    8. Finasteride chemoprevention might be cost-effective in high-risk populations Nature Clinical Practice Urology · 2008
    9. Sometimes Marketing Efforts by Advocacy Organizations Can Lose Touch with the Nuances of Appropriateness Oncology Times · 2004
    10. Basic Scientists Investigate Biochemical Basis of Ancient Chinese Medicines Oncology Times · 2004
    11. Cyberspace Chat International Society of Hair Restoration Surgery · 2007
    12. Pre-receptor regulation of the androgen receptor Molecular and cellular endocrinology · 2007 · 56 citations
    13. Additive in vivo growth-inhibitory effects of flutamide and finasteride on androgen-sensitive Shionogi 115 carcinoma Endocrine-related Cancer · 1996 · 6 citations
    14. Theoretical Evaluation of Twenty-Cannabinoid Derivatives on Either Androgen Receptor or 5α-Reductase Enzyme Clinical cancer investigation journal · 2023 · 3 citations
    15. Evaluation of residual symptoms and anxiety among patients on therapy for benign prostatic hyperplasia at a Nigerian tertiary healthcare facility Journal of Pharmacy & Bioresources · 2026
    16. 테스토스테론으로 유도된 전립선 비대증에 대한 Sapium rotundifolium Hemsl. 추출물의 효과 KMOU Repository (Korea Maritime and Ocean University) · 2019
    17. A new way to restore tumour suppressor function Nature Reviews Drug Discovery · 2013
    18. Abstract SS02-02: Chemoprevention: Poised for Success Cancer Prevention Research · 2008
    19. Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human Endocrinology · 1985 · 193 citations
    20. Investigation, treatment and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendations Andrology · 2005 · 280 citations
    21. Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis Carcinogenesis · 2003 · 138 citations
    22. Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations Andrology · 2006 · 129 citations
    23. Pharmacology and Potential Use of Cyproterone Acetate Hormone and metabolic research · 1977 · 129 citations
    24. Cyproterone Acetate in the Treatment of Sexual Disorders: Pharmacological Base and Clinical Experience Experimental and clinical endocrinology & diabetes · 2009 · 30 citations
    25. Clinical applications of antiandrogens Journal of Steroid Biochemistry · 1988 · 29 citations
    26. Finasteride: The First 5α-Reductase Inhibitor Pharmacotherapy · 1993 · 23 citations
    27. Biomarker-based methods for determining noncompliance in a prevention trial Controlled Clinical Trials · 2002 · 11 citations
    28. Finasteride Expert Opinion on Drug Metabolism & Toxicology · 2010 · 10 citations
    29. Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient Journal of the European Academy of Dermatology and Venereology · 2018 · 9 citations
    30. The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study The Aging Male · 2020 · 6 citations